Schonfeld Strategic Advisors LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1665241
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,967,426
+$1,486,407 QoQ
Shares Held
4,759
+80.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#461
of 1,322 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$7,871,780
PutShares
14,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. REGN ranks #43 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in REGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,967,426 | 4,759 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $7,871,780 | 14,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $1,481,019 | 2,634 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,118,100 | 7,844 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,997,732 | 7,880 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,947,644 | 22,388 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,091,426 | 3,892 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,471,442 | 1,400 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $1,317,435 | 1,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,320,643 | 4,035 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $652,434 | 908 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,981,018 | 3,628 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $3,706,120 | 5,380 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,145,771 | 13,780 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $880,707 | 1,261 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $1,053,618 | 1,741 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $10,708,887 | 19,173 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $4,511,389 | 9,535 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $772,976 | 1,600 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $1,198,263 | 2,454 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||